The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...
A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it’s usefulness.
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...
The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...
The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...
AbbVie's TV spots say that all patients who take the drug, called Ubrelvy, can expect their migraine pain to be eliminated ...
The post Serena Williams Had a Blast in the Circle Pit at Green Day’s Show: Watch appeared first on Consequence. Serena ...